GXUS
Price
$60.86
Change
-$0.94 (-1.52%)
Updated
Oct 22 closing price
Net Assets
619.97M
Intraday BUY SELL Signals
MT
Price
$59.50
Change
-$0.68 (-1.13%)
Updated
Oct 23, 11:57 AM (EDT)
Capitalization
45.28B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GXUS vs MT

GXUS vs MT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GXUS vs. MT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GXUS is a Hold and MT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GXUS with price predictions
Oct 22, 2026

GXUS's RSI Indicator dives into oversold zone

The RSI Indicator for GXUS moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where GXUS advanced for three days, in 98 of 126 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GXUS as a result. In 25 of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 56%.

The Moving Average Convergence Divergence Histogram (MACD) for GXUS turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In 17 of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

GXUS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GXUS crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for GXUS entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for MT with price predictions
Oct 22, 2026

MT's RSI Indicator slumps into oversold zone

The RSI Indicator for MT moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 48 cases where MT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for MT just turned positive on October 20, 2026. Looking at past instances where MT's MACD turned positive, the stock continued to rise in 32 of 45 cases over the following month. The odds of a continued upward trend are 71%.

Following a +1.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where MT advanced for three days, in 222 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

MT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MT as a result. In 53 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

MT moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MT crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for MT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 26 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.826) is normal, around the industry mean (2.211). P/E Ratio (25.286) is within average values for comparable stocks, (35.180). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (0.339). Dividend Yield (0.009) settles around the average of (0.059) among similar stocks. P/S Ratio (0.890) is also within normal values, averaging (2.301).

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating fairly steady price growth. MT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MT: Fundamental Ratings
MT
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GXUSMT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 24 days ago
67%
Bearish Trend 5 days ago
64%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
GXUS
Daily Signal:
Gain/Loss:
MT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GXUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GXUS has been loosely correlated with RIO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if GXUS jumps, then RIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GXUS
1D Price
Change %
GXUS100%
-1.51%
RIO - GXUS
55%
Loosely correlated
-3.20%
MT - GXUS
54%
Loosely correlated
-5.18%
LTM - GXUS
50%
Loosely correlated
-1.81%
AER - GXUS
44%
Loosely correlated
-0.13%
FER - GXUS
43%
Loosely correlated
-0.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLDE27.750.64
+2.36%
Slide Insurance Holdings Inc
INSM95.061.02
+1.08%
Insmed
VTEX4.170.03
+0.72%
VTEX
MYSE1.40N/A
N/A
Myseum.AI Inc.
MENS1.74-0.15
-7.94%
Jyong Biotech Ltd